Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (111-120 of 359) with videos related to

Pageof 36
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 6, 2002
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationshipsJason L J Dearling, Jason S Lewis, Gregory E D Mullen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for ExpertiseHeather A Jacene, Jean-Luc Urbain, Jason S Lewis, et al.
Inorganic Chemistry|September 6, 2014
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistryEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Nuclear Medicine and Biology|July 20, 2005
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSMPaul Burgman, Joseph A O'Donoghue, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2016
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF MutantsJan-Philip Meyer, Kimberly J Edwards, Paul Kozlowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2020
PET/CT Imaging with an <sup>18</sup>F-Labeled Galactodendritic Unit in a Galectin-1-Overexpressing Orthotopic Bladder Cancer ModelPatricia M R Pereira, Sheryl Roberts, Flávio Figueira, et al.
Molecular Imaging and Biology|February 11, 2022
EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder TumorsTran T Hoang, Komal Mandleywala, Tara Viray, et al.
Nature Medicine|September 25, 2012
Annotating MYC status with 89Zr-transferrin imagingJason P Holland, Michael J Evans, Samuel L Rice, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Head-to-Head Evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in Metastatic Invasive Lobular Breast CancerGary A Ulaner, Komal Jhaveri, Sarat Chandarlapaty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivoJason P Holland, Vadim Divilov, Neil H Bander, et al.
Pageof 36

Showing results (111-120 of 359) with videos related to

Sort By:
Pageof 36
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 6, 2002
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationshipsJason L J Dearling, Jason S Lewis, Gregory E D Mullen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for ExpertiseHeather A Jacene, Jean-Luc Urbain, Jason S Lewis, et al.
Inorganic Chemistry|September 6, 2014
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistryEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Nuclear Medicine and Biology|July 20, 2005
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSMPaul Burgman, Joseph A O'Donoghue, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2016
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF MutantsJan-Philip Meyer, Kimberly J Edwards, Paul Kozlowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2020
PET/CT Imaging with an <sup>18</sup>F-Labeled Galactodendritic Unit in a Galectin-1-Overexpressing Orthotopic Bladder Cancer ModelPatricia M R Pereira, Sheryl Roberts, Flávio Figueira, et al.
Molecular Imaging and Biology|February 11, 2022
EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder TumorsTran T Hoang, Komal Mandleywala, Tara Viray, et al.
Nature Medicine|September 25, 2012
Annotating MYC status with 89Zr-transferrin imagingJason P Holland, Michael J Evans, Samuel L Rice, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Head-to-Head Evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in Metastatic Invasive Lobular Breast CancerGary A Ulaner, Komal Jhaveri, Sarat Chandarlapaty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivoJason P Holland, Vadim Divilov, Neil H Bander, et al.
Pageof 36